In this conversation with Ashish Kamat, MD, Arjun Balar, MD, MBBS, discusses testing the concept of effectively treating bladder cancer without needing chemotherapy in the non-muscle-invasive disease space, specifically patients with high-risk carcinoma in situ, with or without papillary tumors that had become unresponsive to Bacillus Calmette-Guerin (BCG) based on the current Federal Drug…
Sam Chang and Siamak (Sia) Daneshmand discuss the ABLE-41 trial, focusing on the real-world usage of nadofaragene firadenovec for bladder cancer. Discussing the trial’s design…
APCCC 2024, Radioligand Therapy, Dosing of Radioligand Therapy, Dosing of Radioligand Therapy in Special Situations And/or Toxicity, 177Lu-PSMA, VISION trial, Lu-PSMA therapy, Lu-PSMA I&T, ENZA-p…
Zachary Klaassen and Stephen Williams delve into the economic and treatment implications of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer. Dr. Williams, with…
APCCC 2024, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), Radioligand Therapy, FDG PET, VISION trial, TheraP trial, 68Ga-PSMA-11, “VISION-TheraP” gap, 177Lu-SPECT/CT imaging, 18F-FDG PET/CT,…
Cora Sternberg discusses the significant advancement in the treatment of urothelial carcinoma, focusing on enfortumab vedotin (EV) in combination with pembrolizumab. This combination, recently approved…
Alicia Morgans and Alberto Bossi discuss the integration of local prostate treatment in metastatic hormone-sensitive prostate cancer, focusing on findings from the PEACE-1 trial and…
prostate cancer, BRCA-Deficient Metastatic Prostate Cancer, metastatic castration-resistant prostate cancer (mCRPC), circulating tumor DNA (ctDNA), DNA damage response (DDR), DDR Genes, BRCA2 in ctDNA, genomic…
Anqi Wang unveils findings from her study published in Nature Genetics. Dr. Wang’s research marks a significant advance in understanding the genetic landscape of prostate…
Ashish Kamat is joined by Gautam Jayram to unravel the complexities of BCG unresponsiveness in bladder cancer treatment. Dr. Jayram emphasizes the importance of understanding…
Kyle Richards delves into the subject of environmental factors influencing bladder cancer, particularly focusing on the potential carcinogenic effects of Agent Orange on non-muscle invasive…
